Boston Scientific Announces Expanded Investment and Exclusive Acquisition Option Agreement with Farapulse, Inc.
Agreement expands company's access to pulsed field ablation technology
MARLBOROUGH, Mass., Sept. 21, 2020 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE: BSX) today announced it has signed an investment agreement with ... Devices, Cardiology, Venture Capital Boston Scientific, Farapulse, pulsed field ablation, atrial fibrillation
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Atrial Fibrillation | Cardiology | Heart | Marketing | Mergers and Aquisitions | Pharmaceuticals | Venture Capital